Email Updates

You are here

Webinar & Meeting Reports

  • March 3, 2013 to March 6, 2013

    The 20th Conference on Retroviruses and Opportunistic Infections (CROI) is a meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic.

  • February 26, 2013

    This 90-minute webinar examined the current state of research into topical microbicides – gels, lubes and devices that can be used to prevent HIV transmission during sex. It provided advocates with an overview of global and European topical microbicide research. The presentations were followed by a question and answer session with our expert speakers.

  • January 29, 2013

    This 90-minute webinar, moderated by Rebekah Webb, provided advocates with an overview of European efforts to develop an HIV vaccine through national and EU-funded programmes. The presentations were followed by a question and answer session with the expert speakers.

  • October 3, 2012

    PrEP researchers discussed ongoing trials of new oral PrEP interventions, including non-daily regimens (also described as “intermittent PrEP”) and new drugs such as maraviroc.

  • September 30, 2012

    The United States Conference on AIDS (USCA) is set for September 30 - October 3, 2012 at Caesars Palace Hotel in Las Vegas, NV. For nearly two decades, USCA has sought “to increase the strength and diversity of the community-based response to the HIV/AIDS epidemic through education, training, new partnerships, collaboration and networking. This year, USCA will work to highlight the changes in our movement that have brought us closer than ever to ending the epidemic, and ways that we can move forward as a community to make this dream a reality.

  • September 18, 2012

    Representatives from the US Food and Drug Administration, the US Centers for Disease Control and Prevention, the World Health Organization, the Southern African HIV Clinicians Society, the British HIV Association and the British Association for Sexual Health and Gilead Sciences will discuss various guidelines on the use of and FDA approval of daily TDF/FTC as PrEP.

  • September 9, 2012 to September 12, 2012

    AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.